Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited is a leading biopharmaceutical company deeply rooted in China, with over 25 years of dedicated service to the pharmaceutical industry. Lee's Pharm is committed to enhancing healthcare through research-driven innovation and a market-oriented approach. The company boasts a fully integrated infrastructure encompassing drug development, clinical trials, regulatory compliance, advanced manufacturing, and strategic sales and marketing operations.

Operating from its headquarters at 1st Floor, Building 20E, 20 Science Park East Avenue, Hong Kong Science Park, Shatin, New Territories, HK, Lee's Pharmaceutical Holdings Limited has cultivated extensive partnerships with more than 20 international companies. This collaboration allows Lee's Pharm to market a diverse portfolio of 23 proprietary, generic, and licensed pharmaceutical products across Mainland China, Hong Kong, Macau, and Taiwan. The company's therapeutic focus spans several critical areas, including cardiovascular health, women's health, pediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. Lee's Pharmaceutical Holdings Limited is actively developing over 40 products through internal research and strategic licensing agreements with companies from the United States, Europe, and Japan.

Lee's Pharm remains dedicated to expanding its impact and contributing to advancements in patient care. With a robust pipeline and a commitment to innovation, Lee's Pharmaceutical Holdings Limited is poised for continued growth and success in the dynamic pharmaceutical landscape. Company information will be completed soon with the support of the company’s management. We invite the manager of Lee's Pharmaceutical Holdings Limited to create a customized and exclusive company showcase and product listing on our platform.